Indirect enzyme-linked immunosorbent assay (ELISA) enables detection and quantification of antigenspecific antibodies in biological samples such as human or animal sera. Most current MERS-CoV serological assays such as neutralization, immunofluorescence, or protein microarray rely on handling of live MERS-CoV in high containment laboratories, highly trained personnel as well as the need for expensive and special equipment and reagents representing a hurdle for most laboratories especially when resources are limited. In this chapter, we describe a validated and optimized indirect ELISA protocol based on recombinant S1 subunit (amino acids 1-725) of MERS-CoV for qualitative and quantitative determination of MERS-CoVbinding antibodies.
validated using a large number of well-characterized human serum samples [8] and could be adapted by any laboratory especially that all required reagents are commercially available.
Materials
Prepare all solutions using deionized water and store them at room temperature or 4 C. Diligently follow all waste disposal regulations when disposing waste materials. 6 . Diluent for primary and secondary antibodies: Primary and secondary antibodies should be diluted in blocking buffer (see Note 3) . Store at 4 C.
Antigen and Conjugates
1. Recombinant MERS-CoV S1 subunit protein.
2. Primary antibody (human or animal serum samples). 
Secondary antibody

Methods
Carry out all procedures at room temperature unless otherwise specified.
Qualitative
Detection of MERS-CoV S1-Specific Antibodies 8. Wash the plate as indicated in steps 4 and 5.
9. Add 100 μL of diluted serum samples or controls to each well, seal the plate, and incubate at 37 C for 1 h (see Note 9).
10. During incubation, dilute appropriate HRP-conjugated secondary antibody in blocking solution according to manufacturer's instructions.
11. Wash the plate as indicated in steps 4 and 5 (see Note 10).
12. Add 100 μL of diluted secondary antibody to each well and incubate at 37 C for 1 h.
13. Wash the plate as indicated in steps 4 and 5 (see Note 11).
14. Add 100 μL of TMB substrate to each well and incubate at room temperature for 30 min in the dark for colorimetric development (see Notes 12 and 13).
15. Stop reaction with equal volume of TMB BlueSTOP solution.
16. Read absorbance in the plate on automated microplate reader at 630 nm (see Note 14).
17. Samples with absorbance above the cutoff value of 0.34 are considered positive (assay sensitivity and specificity are 94.9% and 95.2%, respectively [8] ) (see Note 15).
End-Point
Titration of MERS-CoV S1-Specific Antibodies 1. Coat and block the plate as indicated in the steps 1-6 in Subheading 3.1.
2. In a new sterile U-shaped 96-well plate, add 297 μL blocking buffer to all wells in column 1 (see Note 16).
3. Add 150 μL blocking buffer to all remaining wells in the plate (Fig. 1 ).
4. Add 3 μL from each serum per well in all wells in column 1 to have 1:100 dilution (Fig. 1) . Test each serum sample in duplicates (see Notes 7 and 8).
Add 297 μL blocking buffer to wells in column 1
Add 150 μL blocking buffer to all wells . Perform twofold serial dilutions by transferring 150 μL progressively from column to column using a multichannel pipette ( Fig. 1 ).
6. During each dilution step mix well by pipetting eight times up and down (see Note 17).
7. Discard the final 150 μL after column 12.
8. Wash the incubated plate as indicated in steps 4 and 5 in Subheading 3.1 to remove blocking buffer.
9. Add 100 μL from each dilution to each well using a multichannel pipette, seal the plate, and incubate at 37 C for 1 h (see Note 17).
10. Continue using steps 10-16 from Subheading 3.1 and save the results.
11. The last dilution needs to reach a signal equivalent to the background reading from blocking buffer without serum (see Note 18).
12. The every last dilution that gives twice the signal of the background indicates the end-point titer of the sample; otherwise, antibody titer can be determined using four-parameter logistic (4PL) regression curve in SigmaPlot or GraphPad Prism software.
Notes
1. Use different reagent reservoir for each buffer.
2. Alternatively, carbonate-bicarbonate buffer (50 mM), pH 9.6, could be used as coating buffer: Prepare buffer by adding 2.88 g of sodium bicarbonate (NaHCO 3 ) and 1.67 g of sodium carbonate (Na2CO3) to~980 mL water. Adjust the pH to 9.6 with HCl if needed and complete the volume to 1 L with water.
3. Measure 100 mL of 1Â PBST to a 100 mL graduated cylinder and transfer the volume to a glass bottle. Transfer 5 g skim milk powder into the bottle and stir until dissolved.
4.
Coating buffer helps to bind antigen to the wells. During coating, sealing the plates will help prevent any reagents from evaporating overnight when leaving them in the refrigerator.
5.
Washing the 96-well ELISA plate with PBST will help remove any unbound antigens from the wells.
6. Blocking helps in preventing nonspecific binding of detection antibodies to the microplate surface, reducing signal background and improving the signal-to-noise ratio. Blocking could be done at 4 C for overnight. 18. Higher dilutions of the samples may be required in case the last dilution did not reach a signal equivalent to the background.
